Bluebird Bio reported $39.29M in Trade Creditors for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Acceleron Pharma XLRN:US $ 9.44M 4.97M
Agios Pharmaceuticals AGIO:US $ 7.65M 43.57M
Alexion Pharmaceuticals ALXN:US $ 125.3M 6.7M
Alnylam Pharmaceuticals ALNY:US $ 53.08M 7.7M
Amgen AMGN:US $ 1277M 119M
Applied Genetic Technologies AGTC:US $ 1.93M 0.15M
Arrowhead Research ARWR:US $ 10.04M 4.74M
Avrobio Inc AVRO:US 2.03M 669K
Biogen BIIB:US $ 375.3M 55.1M
Bluebird Bio BLUE:US $ 39.29M 19.06M
Dicerna Pharmaceuticals DRNA:US $ 12.83M 1.55M
Immunogen IMGN:US $ 11.63M 1.28M
Intercept Pharmaceuticals ICPT:US $ 15.09M 2.51M
IONIS PHARMACEUT IONS:US $ 14.66M 5.15M
Mirati Therapeutics MRTX:US $ 23.87M 4.27M
Moderna Inc MRNA:US 77M 69M
Nektar Therapeutics NKTR:US $ 19.7M 2.73M
Novartis NOVN:VX 4.81B 229M
Ptc Therapeutics PTCT:US $ 20.82M 1.71M
Regeneron Pharmaceuticals REGN:US $ 476M 66.9M
Sangamo Biosciences SGMO:US 10.13M 1.51M
Sarepta Therapeutics SRPT:US $ 76.68M 0.03M
Seattle Genetics SGEN:US $ 102.4M 5.64M
Ultragenyx Pharmaceutical RARE:US $ 21.79M 6.05M
Vertex Pharmaceuticals VRTX:US $ 127.53M 0.3M
YTE INCY:US $ 122.1M 37.04M